Ace the SOCRA CCRP Exam 2025 – Become a Clinical Superstar!

Question: 1 / 400

What FDA regulation allows investigators to withdraw a subject's participation at any time?

21 CFR 50.25(b)(2)

FDA regulation 21 CFR 50.25(b)(2) specifically states that investigators have the right to withdraw a subject's participation in a study at any time. This is an important regulation to ensure the safety and rights of participants. Choices B, C, and D do not pertain to this specific regulation and do not address the issue of withdrawing a subject's participation. Choice B deals with labeling requirements for over-the-counter drug products, choice C pertains to the review and approval of clinical investigations by an institutional review board, and choice D relates to the submission of marketing application and standards for drugs and biologics. These options do not address the specific concern of withdrawing a subject's participation, making them incorrect choices.

Get further explanation with Examzify DeepDiveBeta

21 CFR 310.305

21 CFR 56.108

21 CFR 314.80

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy